The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

G.R. Askerkhanov

R.P. Askerkhanov Medical Center, Makhachkala, Russia

.R. Askerkhanova

Kafedra akusherstva i ginekologii fakul'teta povysheniia kvalifikatsii i poslediplomnoĭ podgotovki spetsialistov Dagestanskoĭ gosudarstvennoĭ meditsinskoĭ akademii

A.U. Cherkesova

Kafedra akusherstva i ginekologii fakul'teta povysheniia kvalifikatsii i poslediplomnoĭ podgotovki spetsialistov Dagestanskoĭ gosudarstvennoĭ meditsinskoĭ akademii

Sh.Sh. Radzhabova

Nauchno-problemnaia laboratoriia perinatal'noĭ meditsiny i reproduktologii Dagestanskogo nauchnogo meditsinskogo tsentra, kafedra akusherstva i ginekologii fakul'teta poslediplomnogo obrazovaniia Dagestanskoĭ gosudarstvennoĭ meditsinskoĭ akademii

Experience with the antiviral drug Panavir used against cytomegalovirus infection in women with recurrent miscarriage

Authors:

G.R. Askerkhanov, .R. Askerkhanova, A.U. Cherkesova, Sh.Sh. Radzhabova

More about the authors

Views: 977

Downloaded: 11


To cite this article:

Askerkhanov GR, Askerkhanova R, Cherkesova AU, Radzhabova ShSh. Experience with the antiviral drug Panavir used against cytomegalovirus infection in women with recurrent miscarriage. Russian Bulletin of Obstetrician-Gynecologist. 2015;15(6):72‑75. (In Russ.)
https://doi.org/10.17116/rosakush201515672-75

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation



We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.